Introduction {#s1}
============

Hydrogen sulfide (H~2~S) is a pungent gas that smells like rotten eggs, and has been identified as the third gaseous transmitter, following nitric oxide (NO) and carbon monoxide (CO; Gallego et al., [@B15]). Since the discovery of its synthesis in mammalian and human tissues, it has attracted much interest as an endogenous mediator in recent years (Whiteman et al., [@B75]). Over the last decade, H~2~S has been recognized to have various biological effects in human health and diseases, such as in the nervous system, the cardiovascular system, and the immune system (Kimura, [@B25]; Wang et al., [@B72]). Recently, studies involving the physiological and pathophysiological effects of H~2~S in the gastrointestinal tract (GI tract) have attracted much attention. Multiple studies also imply the important role of H~2~S in colonic diseases, including inflammatory bowel disease (IBD; Wallace et al., [@B71]; Hirata et al., [@B21]) and colorectal cancer (CRC) (Cai et al., [@B5]; Cao et al., [@B6]; Kimura, [@B25]). In the present review, we will discuss the endogenous and exogenous production of H~2~S, and its biological and pathological roles in IBD and CRC.

Endogenous production and biological roles of H~2~S {#s2}
===================================================

The concentration of H~2~S ranges from 0.2 to 1 mmol/L in the colon of mice and may reach 3.4 mmol/L in human stools (Rose et al., [@B53]). Under normal conditions, approximately 70% of H~2~S is produced from cysteine and the other 30% from homocysteine (Chiku et al., [@B8]). There are three principal enzymes involved in the endogenous production of H~2~S: cystathionine β-synthase (CBS), cystathionine γ-lyase (CSE) and 3-mercaptopyruvate sulfurtransferase (3-MST). They are expressed in many organs, including the liver, kidney, ileum, and brain (Kimura, [@B25]). CBS and CSE have been investigated widely, and both use vitamin B6 as a cofactor to catalyze the production of H~2~S (Chiku et al., [@B8]). The catalytic effect of CBS changes with the extent of allosteric activation of S-adenosylmethionine (Singh et al., [@B61]), and the activity of CSE is enhanced by sodium nitroprusside (SNP; Chiku et al., [@B8]). A study also shows that CSE is regulated by calcium calmodulin, although the requirement for Ca^2+^ concentrations is quite high (1 mM; Yang et al., [@B80]). The role of 3-MST along with cysteine aminotransferase (CAT), which can efficiently produces H~2~S from cysteine and a-ketoglutarate (Kimura, [@B25]), in regulating endogenous H~2~S levels has recently been examined in specific types of cells and tissues (Shibuya et al., [@B60]; Wang, [@B74]).

H~2~S may function as a signal molecule immediately after released from the enzyme; it can also be stored as bound sulfane sulfur, which may in turn release H~2~S (Whiteman et al., [@B75]). At physiological pH, nearly two-thirds of H~2~S exists as the hydrosulfide anion (HS^−^), which is a powerful nucleophile (Bouillaud and Blachier, [@B4]).

Endogenous H~2~S performs vital roles in many physiological processes, including vasorelaxation, angiogenesis, cellular energy production, neuromodulation, cytoprotection, and pathological processes (Figure [1](#F1){ref-type="fig"}; Kimura et al., [@B26]; Coletta et al., [@B10]), and it is now considered as a signaling modulator or a messenger molecule (Farrugia and Szurszewski, [@B13]). H~2~S was initially considered as a neuromodulator that aids the induction of hippocampal long-term potentiation (LTP) by enhancing NMDA-induced currents in neurons (Abe and Kimura, [@B1]; Nagai et al., [@B43]). H~2~S may also mediate the reciprocal interactions between glial calcium waves and neuronal activity, which has not been fully investigated (Kimura, [@B25]). Prior studies also showed that transient receptor potential (TRP) channels might be involved in the effects of H~2~S (Patacchini et al., [@B46]; Gratzke et al., [@B17]).
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H~2~S also functions as signal molecule in smooth muscle relaxation. Although NO performs most of the vessel-relaxing work in large vessels, H~2~S may be responsible for similar actions in smaller blood vessels (Wang, [@B73]). The mechanisms of H~2~S-mediated vasodilation may involve the activation of K~ATP~ channels or other channels, the inhibition of phosphodiesterases and synergy with NO (Wang, [@B74]).

The important pro-angiogenic role of H~2~S has also been recognized (Coletta et al., [@B10]). Angiogenesis is a complex biological process involved in endothelial cell proliferation, migration, and formation of capillary structures (Roudsari and West, [@B54]). Pupo et al. showed that endogenous H~2~S is involved in the angiogenic effects of vascular endothelial growth factor (VEGF), a key growth factor and tumor-derived angiogenic hormone (Pupo et al., [@B49]). Other studies showed that H~2~S exerts its effects via multiple mechanisms including activation of VEGFR2, stimulation of potassium channels and increase of cellular glutathione (GSH) levels (Cai et al., [@B5]; Cao et al., [@B6]; Kimura et al., [@B26]; Tao et al., [@B68]).

In addition to serving as a signal molecule, H~2~S also participates in concentration-dependent modulation of mitochondrial function and cellular bioenergetics. In various cell types (including intestinal epithelial cells and hepatocytes), low concentrations of H~2~S act as mitochondrial electron donors, which results in the stimulation of bioenergy (Szabo et al., [@B67]). They increase the levels of glutathione and redistribute it to the mitochondria. In addition, they can promote the catalytic activity of the glycolytic enzyme GAPDH (Mustafa et al., [@B42]). Endogenous H~2~S may also serve as a bioenergetic stimulator (Modis et al., [@B37],[@B40]). H~2~S produced by 3-MST along with CAT can scavenge reactive oxygen species in mitochondria and protect cells from oxidative stress (Kimura et al., [@B26]). Modis et al. demonstrated that H~2~S donors could stimulate mitochondrial electron transport and ATP generation in various cell lines *in vitro* (Modis et al., [@B39]).

However, when the concentrations of this molecule are relatively high, the stimulatory effect of H~2~S is superseded by an inhibitory effect (Szabo et al., [@B67]), and high concentration of H~2~S may become a broad-spectrum poison to the nervous system, respiratory system and cardiovascular system (Wang, [@B74]). The concentration of H~2~S produced naturally in the human body is much lower than the toxic levels, which may be necessary for cell survival (Kimura, [@B25]).

The complexities of H~2~S biology may be related to its pharmacology. It is a diffusible gas and has a bell-shaped or biphasic dose-response curve, whereby lower concentrations of H~2~S show quite different (often, opposing) effects compared with higher concentrations (Szabo et al., [@B64]). Lower levels of H~2~S exert multiple physiological, cytoprotective, antioxidant and, anti-inflammatory functions. At higher local levels, however, H~2~S can become prooxidant, cytostatic, and cytotoxic (Baskar and Bian, [@B3]). However, these studies are limited by the lack of enzyme-specific inhibitors to target H~2~S biosynthesis, which may be related to the above-mentioned controversial observations (Whiteman et al., [@B75]).

Biological roles of H~2~S in the GI tract {#s3}
=========================================

Emerging evidence indicate that endogenous H~2~S can be produced and released by colonic tissue (Linden et al., [@B31]; Cao et al., [@B6]). In the GI tract H~2~S is mainly produced by CBS and CSE. CSE seems to be the main H~2~S-generating enzyme in the stomach, while CBS is the major enzyme in the colon (Wallace et al., [@B71]). The functions of H~2~S in the GI tract have also received much attention in recent years. It can relax ileal smooth muscle, increase colonic secretion (Gallego et al., [@B15]; Matsunami et al., [@B35]), and protect the intestines from ischemia--reperfusion injury in rats (Liu et al., [@B32]). However, high levels of H~2~S may also cause diseases, such as IBD and CRC.

Roles of exogenous H~2~S donors {#s4}
===============================

There are multiple reports related to exogenous H~2~S donors in tumor cells that either promote or inhibit cell proliferation at different concentrations (Baskar and Bian, [@B3]; Wu et al., [@B78]). Previous studies have attempted to use various molecules to produce H~2~S (Kashfi and Olson, [@B24]), such as NSAIDs (Chattopadhyay et al., [@B7]; Kashfi, [@B23]), GYY4137 \[morpholin-4-ium 4 methoxyphenyl (morpholino)\] (Ning et al., [@B44]), S-propargyl-cysteine (Ma et al., [@B34]), Sodium hydrosulfide (NaHS) (Cai et al., [@B5]), Na~2~S (Hirata et al., [@B21]). The pros and cons of these molecules are summarized in a review article by Hellmich et al. ([@B19]). Among them NaHS is most widely used to study the physiological functions of H~2~S. NaHS is a fast-release H~2~S donor, which immediately dissociates and forms the hydrosulfide anion (HS^−^) in the liquid culture, and reacts with H^+^ to form H~2~S.

Many studies have reported duplex effects of H~2~S on cell proliferation/cell death in various transformed and non-transformed cell lines *in vitro* (Leschelle et al., [@B28]; Cai et al., [@B5]; Murata et al., [@B41]). Baskar et al. have summarized most of these reports in a review article (Baskar and Bian, [@B3]). Note that the effects of H~2~S donors are bi-phasic, just like endogenously produced H~2~S. Cai et al. reported a concentration-dependent stimulation of cell growth by NaHS at doses between 10 and 50 μM, a plateauing of the effect at 200 μM, and an inhibition of proliferation at 1000 μM in HCT116 and SW480 cells (Cai et al., [@B5]). Hellmich et al. also demonstrated that the nature of the cellular response (stimulation or inhibition of growth) is determined by the rate of H~2~S production (fast- vs. slow-release H~2~S donors) as well as by the concentration of donor relative to the basal level of endogenous enzyme-dependent H~2~S production (Hellmich et al., [@B19]). It should be considered that H~2~S donors with different release rates might induce quantitative, as well as qualitative, variance in cellular responses (Whiteman et al., [@B76]; Baskar and Bian, [@B3]).

Thus, the bell-shaped properties of H~2~S provide a useful framework to reconcile some of the controversies regarding H~2~S functions. However, the complexities of the temporal relationship between H~2~S donation and its effects remain to be further explored.

Bacteria associated with hydrogen sulfide metabolism {#s5}
====================================================

H~2~S was one of the earliest products of bacterial decomposition to be recognized (Shatalin et al., [@B58]). Sulfur reduction and oxidation are handled by two different groups of bacteria. The former comprise the sulfate-reducing bacteria (SRB) and sulfur-reducing bacteria, while the latter includes sulfur-oxidizing bacteria and sulfide-oxidizing bacteria (Wang, [@B74]). They both contribute to a balanced H~2~S level in a given environment. Among them, SRB belong to the most ancient forms of bacteria and utilize a wide range of substrates, including hydrogen, short-chain fatty acids, alcohols and amino acids to reduce sulfur and sulfur-containing compounds to H~2~S (Scanlan et al., [@B56]).

SRB are Gram-negative, non-spore-forming, obligate anaerobes. SRB are considered to be strictly anaerobic microorganisms, but they are also found in anoxic habitats depleted of sulfate, such as the GI tract (Rey et al., [@B51]). Although Hansen et al. demonstrated the lack of SRB in human gut microbiota (Hansen et al., [@B18]), other studies using different analytic approaches have identified SRB in the fecal microbiota of healthy adults and the distal gut mucosa (Stewart et al., [@B62]; Rey et al., [@B51]). The number of healthy individuals harboring SRB ranged from 24 to 100% (Loubinoux et al., [@B33]). The most frequently detected SRB from animal and human feces that are relevant to bowel colonization are *flagellate Vibrio bacteria* and *Desulfovibrio* (Scanlan et al., [@B56]).

For bacterial-derived H~2~S, little is known about the metabolic pathways involving host cellular processes. Huycke et al. showed that H~2~S produced by SRB in the GI tract is potentially genotoxic to the gut epithelium (Huycke and Gaskins, [@B22]). However, Konstantin et al. demonstrated that H~2~S produced by SRB acts as a cytoprotectant molecule against oxidative stress and antimicrobials by suppressing the DNA-damaging Fenton reaction and stimulating the major antioxidant enzymes catalase and superoxide dismutase (SOD) (Shatalin et al., [@B58]). Moreover, Devkota et al. found that SRB are positively associated with inflammation (Devkota et al., [@B11]): both pro- and anti-inflammatory signaling is attributed to H~2~S (Pitcher et al., [@B48]; Wallace et al., [@B71]). In conclusion, bacterial-derived H~2~S may have important roles in the GI tract, but the conclusions remain to be further explored.

Roles of H~2~S in the pathophysiology of IBD and CRC {#s6}
====================================================

IBD
---

The incidence of IBD and other immune-related human disorders have increased considerably over the past 50 years, matching the changes in human diet and lifestyle. The pathological roles of colonic luminal H~2~S and/or SRB in IBD have attracted much attention recently (Roediger et al., [@B52]; Wallace et al., [@B71]; Hirata et al., [@B21]). However, the viewpoint that H~2~S contributes to the pathogenesis of IBD remains controversial (Table [1](#T1){ref-type="table"}). It has been reported previously that high levels of H~2~S produced by bacteria could contribute to ulcerative colitis (UC) by damaging oxidation of n-butyrate, leading to impaired barrier function (Levitt et al., [@B29]). However, several studies have challenged the idea for the lack of compelling evidence that H~2~S causes damage to colonic epithelial cells, and have demonstrated that H~2~S can act as a metabolic fuel for colonocytes (Goubern et al., [@B16]; Picton et al., [@B47]). Wallace et al. reported significant accumulation of H~2~S after induction of colitis in rats and inhibition of H~2~S synthesis exacerbates colitis, suggesting that H~2~S contributes to the resolution of experimental colitis (Wallace et al., [@B71]). Recently, Hirata et al. also confirmed that endogenous H~2~S acted as an anti-inflammatory molecule by preventing neutrophil accumulation and via its anti-oxidant ability, suggesting cytoprotective effects of H~2~S (Hirata et al., [@B21]).

###### 

**Roles of H~2~S in the pathophysiology of IBD and CRC**.

  **Diseases**   **Effects of H~2~S**        **Possible pathogenesis/Epidemiologic study**                             **References**
  -------------- --------------------------- ------------------------------------------------------------------------- ---------------------------------------------------------------
  IBD            Pro-inflammatory effects    Impaired oxidation of n-butyrate                                          Levitt et al., [@B29]
                                             Patients with UC had excessive SRB colonization or H2S in feces           Pitcher et al., [@B48]; Rowan et al., [@B55]
                 Anti-infammatory effects    Suppression of the activation of NF-kB                                    Oh et al., [@B45]
                                             Promotion of ucler healing in rats                                        Wallace et al., [@B70]
                                             Downregulation of TNF-α,IFN-γ and iNOS epression                          Li et al., [@B30]; Wallace et al., [@B69]
                                             Contribution to the resolution of experimental colitis                    Wallace et al., [@B71]
                                             Acting as an antioxidant                                                  Hirata et al., [@B21]
                                             Preventation of neutrophil accumulation and viaits anti-oxidant ability   Hirata et al., [@B21]
                 No effects                  No difference in SRB between patients with IBD and controls               Fite et al., [@B14]; Picton et al., [@B47]
  CRC            Carcinogenic factor         Decrease of suifide-detoxifying enzymes                                   Ramasamy et al., [@B50]
                                             Genomic DNA damage                                                        Attene-Ramos et al., [@B2]
                                             Stimulation of the growth and migration                                   Cai et al., [@B5]; Szabo et al., [@B64]; Modis et al., [@B38]
                                             Inhibition of cell apoptosis                                              Sen et al., [@B57]
                                             Stimulation of tumor angiogenesis and peritumoral vasodilation            Szabo et al., [@B64]
                 Cancer suppressive factor   Reduction of cell viability                                               Cao et al., [@B6]
                                             Inhibition of proliferation and promotion of protective autophagy         Wu et al., [@B78]

Although the functions of endogenous and exogenous H~2~S in IBD remains controversial, many prior studies have shown multiple effects of H~2~S. It can downregulate the expression of several pro-inflammatory cytokines and enzymes, such as TNF-α, IFN-γ and iNOS (Li et al., [@B30]; Wallace et al., [@B69]); suppress the activation of NF-κB (Oh et al., [@B45]); act as an antioxidant (Hirata et al., [@B21]); and promote ulcer healing in rats (Wallace et al., [@B70]). The colonic mucosa is endowed with an efficient H~2~S-detoxifying mechanism, oxidizing more than 300 μmol of H~2~S daily in the rat colon (Suarez et al., [@B63]). When the barrier breaks down, such as in severe colitis, a large amount of H~2~S may access the muscle layers and inhibit motility.

In addition, the contribution of bacteria-derived H~2~S in colitis remains unclear. An epidemiologic study revealed that patients suffering from UC had either excessive SRB colonization or excessive H~2~S in their feces (Pitcher et al., [@B48]; Rowan et al., [@B55]). Kleessen et al. reported variable counts of SRB from colonic mucosal specimens in patients with UC, Crohn\'s disease (CD) and healthy controls (Kleessen et al., [@B27]). However, Picton et al. found no evidence of defective enzymic detoxication of sulfide in patients with UC or CD (Picton et al., [@B47]). Fite et al. also confirmed that there is no disease-related difference in SRB carriage between patients with UC and controls by rectal biopsies (Fite et al., [@B14]).

In summary, endogenously and exogenously produced H~2~S in the GI tract might contribute to colitis and IBD, but there is no complete mechanistic model that explains the relationship.

CRC
---

CRC is the second leading cause of death from cancer and the fourth most common cancer in men and women worldwide. H~2~S is also implicated in CRC (Huycke and Gaskins, [@B22]; Cai et al., [@B5]; Cao et al., [@B6]; Hellmich and Szabo, [@B20]). Although the basal expression of H~2~S-synthesizing enzymes in human colon tissue is relatively low (Whiteman et al., [@B75]), Szabo et al. observed the selective upregulation of CBS in the colon cancer tissue compared to normal mucosa tissue (Szabo et al., [@B64]). The expression of CBS is also upregulated in certain colon adenocarcinoma-derived cell lines (HCT-116, HT-29, and LoVo) compared with the colonic epithelial cell line. (Szabo and Hellmich, [@B65]) Genomic DNA damage is observed in colon cells after H~2~S exposure (Attene-Ramos et al., [@B2]). In addition, sulfide-detoxifying enzymes in the human colon are decreased in cancer tissues (Ramasamy et al., [@B50]).

Recently, several studies suggested that H~2~S regulated cell growth or death in a multitude of settings (Cai et al., [@B5]; Cao et al., [@B6]; Medani et al., [@B36]; Szabo et al., [@B64]). Cai et al. demonstrated that H~2~S promoted colon cancer cell proliferation, as mentioned previously (Cai et al., [@B5]). However, Cao et al. demonstrated that H~2~S is endogenously produced in colonic tissues and that exogenously applied H~2~S at physiologically concentrations reduced cell viability (Cao et al., [@B6]). Another study showed that H~2~S could inhibit proliferation and promote protective autophagy in colon epithelial cells by the activation of the AMPK/ mTOR cascade (Wu et al., [@B78]). Previous studies have shown cell type-specific activation of MAPK by H~2~S, which determines the fates of cells (Cho et al., [@B9]; Shibuya et al., [@B59]; Cao et al., [@B6]). These controversies may relate to the bell-shaped dose-response curve of H~2~S.

For tumor-produced CBS-derived H~2~S in CRC, Szabo et al. defined this gas as a combined autocrine and paracrine-signaling molecule (Szabo and Hellmich, [@B65]). As an autocrine factor, H~2~S stimulates the proliferation and migration of CRC cells (Cai et al., [@B5]; Szabo and Hellmich, [@B65]; Szabo et al., [@B64]; Modis et al., [@B38]). However, at higher concentrations or longer exposures to S-adenosyl-L-methionine (SAM), the inhibitory effects become more prominent because of cytotoxicity. Recently, Sen et al. found that the sulfhydration of nuclear factor kappa B (NF-kB) by H~2~S could inhibit cell apoptosis (Sen et al., [@B57]). The mechanisms of the proliferative and pro-migratory effects might be the stimulation of the Akt/PI3K signaling pathway, decrease of p21 gene expression and interaction with NO (Cai et al., [@B5]).

As a paracrine factor, H~2~S might diffuse out from the tumor cell to stimulate tumor angiogenesis and peritumoral vasodilation. Szabo et al. reported that treatment of nude mice with a CBS inhibitor could attenuate the growth of patient-derived colon cancer xenografts and reduce peritumoral blood flow (Szabo et al., [@B64]). This study also confirmed the stimulatory role of H~2~S on the activity of GAPDH, indicating that H~2~S can affect both oxidative and glycolytic metabolism in tumor cells. Another independent study also confirmed the autocrine and paracrine functions of colon cancer-derived H~2~S (Yamagishi et al., [@B79]). Yamagishi et al. detected significant amounts of H~2~S inside colon cancer tissue.

Subsequent studies in nude mice bearing xenografts of either HCT116 or patient-derived tumor tissue (PDTX) extended the findings into *in vivo* models. Inhibition of CBS significantly reduced the growth rate of the tumor xenografts, which might be related to intratumoral mechanisms or paracrine mechanisms in the tumor microenvironment (Hellmich and Szabo, [@B20]). In addition, CSE can stimulate colon cancer cell proliferation, migration *in vitro* and tumor xenografts growth *in vivo*, however, the roles of CSE/H~2~S in colon cancer remain uncertain. Another study demonstrated that the canonical Wnt pathway can upregulate CSE expression (Fan et al., [@B12]).

Thus, H~2~S may exhibit both protective and pathological effects in the GI tract given its biphasic pharmacological characters. However, the prior studies demonstrated controversial effects of H~2~S and the mechanisms remain unknown.

The therapeutic potential of H~2~S in colonic diseases {#s7}
======================================================

Although limited in terms of quantity and mechanistic models, there is reasonable evidence suggesting that H~2~S is important for the occurrence and development of colonic diseases. The intriguing discovery that H~2~S governs specific protective responses against oxidative stress and antibiotics also suggested the potential therapeutic implications (Shatalin et al., [@B58]). We can hypothesize that H~2~S inhibition might be potentially applicable to inhibition of tumor blood supply and/or the hyperproliferative response in CRC. Given the particular pharmacological character of H~2~S, both stimulation and inhibition of H~2~S might have potential therapeutic applications (Szabo and Papapetropoulos, [@B66]).

In addition, it is noted that exposure to a relatively low level of H~2~S over a relatively long time period selectively inhibits cancer cell proliferation. Therefore, slow-releasing H~2~S donors and H~2~S-releasing hybrid drugs could be designed and developed as novel anticancer drugs (Wu et al., [@B77]). However, these possibilities are merely hypothetical at present, and the lack of wholly enzyme- and tissue-specific inhibitors of H~2~S has meant that controversial or contradictory conclusions have been made in previous studies.

In conclusion, H~2~S might play vital roles in the development of colonic diseases, and further investigations are needed to determine the proper dose range and time frame of H~2~S in IBD and CRC, thereby achieving optimal anti-inflammation and anti-cancer effects.

Author contributions {#s8}
====================

FG collected the references and wrote the majority of the manuscript; TY helped with the preparation and the revision of the manuscript; JH contributed to the correction of the grammar and terminology; JF contributed to the final version of the manuscript.

Conflict of interest statement
------------------------------

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

[^1]: Edited by: Ghanshyam Upadhyay, City College of New York, USA

[^2]: Reviewed by: Georg Singer, Medical University of Graz, Austria; Nagaraja Nagre, Eastern Virginia Medical School, USA; Israr Ahmad, University of Alabama at Birmingham, USA

[^3]: This article was submitted to Gastrointestinal Sciences, a section of the journal Frontiers in Physiology
